Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2020
CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic featuresErik A Williams, Meagan Montesion, Brian M Alexander, et al.
The Oncologist|May 7, 2016
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical TrialsJames H Suh, Adrienne Johnson, Lee Albacker, et al.
Molecular Endocrinology (Baltimore, Md.)|May 29, 2001
Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian functionC Yan, P Wang, J DeMayo, et al.
Cancer Medicine|January 15, 2026
Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic ImplicationsDouglas I Lin, Elizabeth Lawrence, Natalie Danziger, et al.
Breast Cancer Research and Treatment|January 15, 2016
Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling studyJeffrey S Ross, Laurie M Gay, Sahar Nozad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2023
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancerBreana L Hill, Ryon P Graf, Kunal Shah, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2021
Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" TumorsVivienne T Meljen, Rhonda Mittenzwei, Janice Wong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profilesErik A Williams, Nikunj Shah, Meagan Montesion, et al.
The American Journal of Dermatopathology|January 4, 2017
Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic MelanomaJ Andrew Carlson, Jose Candido Caldeira Xavier, Ashley Tarasen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2020
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutationsErik A Williams, Meagan Montesion, Nikunj Shah, et al.
Pageof 16